Navigation Links
Napo in Medical News

Napo Pharmaceuticals Announces License of Crofelemer to Salix Pharmaceuticals

... SAN FRANCISCO, Dec. 10 /PRNewswire/ -- napo Pharmaceuticals, Inc. ("Napo") is pleased to annou... of $500,000 for the purchase of 250,000 shares of napo common stock; as well as regulatory and sales mile...llaboration Agreement) will include a reference to napo as the licensor and will include Napo's logo and r...

Napo Obtains Special Protocol Assessment Agreement From FDA for Crofelemer

... napo Pharmaceuticals, Inc., which focuses on the develo...r an FDA Fast Track designation. On Jan. 16, 2007, napo met with the FDA under the Special Protocol Assess...ive design of its ADVENT trial. On March 14, 2007, napo announced it had received approval from the princi...
Napo in Medical Technology

Napo Announces Positive Clinical Data Indicating Crofelemer, Could Effectively Treat Cholera

... SAN FRANCISCO, Sept. 22 /PRNewswire/ -- napo Pharmaceuticals (LSE: NAPL/NAPU) today announces p...tic, azithromycin, and rehydration therapy. Both napo and ICDDR, B, upon receipt of additional funding, ...al Institutes of Allergy and Infectious Disease. napo is currently conducting a Phase 3 trial for crofel...

Napo Presents at ISPOR Meeting in Toronto

...um of anti-retroviral drugs. We are pleased to see napo taking the initiative to develop this new instrume...rhea." For more information please contract: napo Pharmaceuticals, Inc. Lisa Conte, Chief Executive...ector, Clinical Operations 1+ 760 918 5718 About napo Pharmaceuticals, Inc. ...

Napo Announces Successful Clinical Results in Phase 2 Study of Crofelemer in Acute Adult Infectious Diarrhea

...n travelers in Mexico and Jamaica with crofelemer, napo is investigating the regulatory pathway to file an...diarrhea in people living with HIV/AIDS (CRO-HIV). napo is targeting an NDA filing for CRO-HIV around the end of the year. napo has exclusive worldwide rights to crofelemer in al...

Glenmark Initiates Phase 2 Trial for Crofelemer for Acute Infectious Diarrhea

...ritories, Glenmark will pay ascending royalties to napo on sales of crofelemer for these indications. Gl...3 2008." For more information please contact: napo Pharmaceuticals, Inc. Lisa Conte, Chief Executive... 7466 5000 Tim Anderson, Mary-Jane Johnson About napo Pharmaceuticals, Inc. ...

Phase 2a Diarrhea Predominant Irritable Bowel Syndrome Results from 2006 Presented at Digestive Disease Week in Washington, D.C.

...CO, Calif., May 23, 2007 /PRNewswire-FirstCall/ -- napo Pharmaceuticals, Inc., , which focuses on the deve... licensed crofelemer for the d-IBS indication from napo in June 2004. Trine has worldwide development and ... For more information please contact: napo Pharmaceuticals, Inc Lisa Conte, Chief Execut...
Napo in Biological Technology

Insmed Announces Fourth Quarter and Full-Year 2008 Financial Results

...MMD trial. This was partially offset by the absence of license income from napo and the revenues lost from our withdrawal of IPLEX(TM) in the short stature...00,000 loss on investments represents the full write down on the prior year napo investment during 2008. As of December 31, 2008, we had total cash, ca...

Insmed Announces Financial Results for Third Quarter and Nine-Months Ended September 30, 2008

...m Napo, was recorded as part of our agreement with napo in 2007. For the nine months ended September 30,...ially offset by the absence of license income from napo and the revenues lost from our withdrawal of IPLEX... investments represents the full write down of the napo investment during the first nine months of 2008. ...

Napo Pharmaceuticals Will Provide Pediatric Formulation of Crofelemer at Cost to Developing Nations to Help Treat Life-Threatening Diarrhoel Diseases (Subject to FDA Approval)

...ar NEW YORK, Sept. 25 /PRNewswire-USNewswire/ -- napo Pharmaceuticals, Inc., ("Napo") of South San Franc...uch as HIV/AIDS and cholera. As part of the CAP, napo and Direct Relief International ("DRI") have formed an alliance whereby napo will provide CRO-PED at cost for distribution thro...

Insmed Announces Financial Results for Second Quarter and Six-Months Ended June 30, 2008

... absence of license income from our agreement with napo Pharmaceuticals Inc., ("Napo") from which we recei...ially offset by the absence of license income from napo and the revenues lost from our withdrawal of IPLEX...ss on investments represents the write down on the napo investment during the first half of 2008. Intere...

Insmed Announces First Quarter 2008 Financial Results

...and Tercica Inc., and the absence of license income from our agreement with napo Pharmaceuticals Inc., ("Napo") from which we received a milestone payment i...y a milestone payment from Napo, was recorded as part of our agreement with napo in 2007. Interest income in the first quarter of 2008 at $279,000 was sli...

IBF Conferences Inc*International Business Forum and BioEnterprise Corporation present the 2nd Annual Global Healthcare Investing Conference

... Group Ltd. Hoersholm, Denmark Santaris BioPharmaceutical Pharmaceutical California, USA napo Pharmaceutical BioPharmaceutical Wurmlingen, Paradigm Spine, LLC Devices Germany Tokyo, Japan EyePlusPlus,...

Insmed Announces Fourth Quarter and Full-Year 2007 Financial Results

...ng period of 2006. This increase was due to improvements in the cost recovery from our EAP and the receipt of licensing income from our agreement with napo Pharmaceuticals Inc., ("NAPO"), combined with increased sales of IPLEX(TM) during the first quarter of 2007. The net loss for the 12 months ended De...

M. Scott Harris, M.D., Joins Ocera Therapeutics, Inc., as Chief Medical Officer

...pany as Chief Medical Officer. Prior to joining Ocera, Dr. Harris held the position of Chief Medical Officer and Vice President of Clinical Affairs at napo Pharmaceuticals. Dr. Harris has extensive experience in gastrointestinal diseases as well as clinical and regulatory operations. "We are delighted b...
Other Tags
(Date:12/26/2014)... 2014 Parker & Sons, Inc. ... in heating, cooling and plumbing contractor services throughout ... services in 2014 with regard to air-conditioning systems. ... is known for its incredibly hot summers. Working ... intricacies and details of a wide variety of ...
(Date:12/25/2014)... 2014 The click strand ... strength and durability. Today, the business announces a ... valid until Jan. 30, 2015. , Click strand ... hardwood. BambooFlooringChina.com is a well-known brand in the ... to find a reliable bamboo flooring supplier. , ...
(Date:12/25/2014)... 2014 Product liability lawsuits filed in ... ( http://www.consumerinjurylawyers.com/DePuy/ ) continue to move forward in federal ... issued in the U.S. District Court, Northern District of ... open conference on January 7, 2015, at the Paul ... West Palm Beach, Florida. The Conference is scheduled to ...
(Date:12/25/2014)... Recently, Dylan Queen, a famous online company supplying ... of discounted prom dresses, most of which are priced ... the company, the promotion is valid until Jan. 22, ... the UK market. , The prom dresses in this ... styles: A-line strapless, empire strapless chiffon, one shoulder, floor-length, ...
(Date:12/25/2014)... sells many bamboo products and the business is famous ... announces big discounts on its bamboo mats , which ... the world’s leader in bamboo flooring. According to the ... 2015. , The bamboo mats are made from well-treated ... the bamboo strips for the mats are boiled and ...
Breaking Medicine News(10 mins):Health News:Parker & Sons Announces Record Demand For 24 Hour Emergency Services In 2014 With Regard To Air-Conditioning Systems 2Health News:Parker & Sons Announces Record Demand For 24 Hour Emergency Services In 2014 With Regard To Air-Conditioning Systems 3Health News:BambooFlooringChina.com: click strand woven bamboo flooring promotion valid until Jan. 30, 2015. 2Health News:Federal Court Overseeing DePuy ASR Hip Lawsuit Set to Convene Conference in January, Bernstein Liebhard LLP Reports 2Health News:Federal Court Overseeing DePuy ASR Hip Lawsuit Set to Convene Conference in January, Bernstein Liebhard LLP Reports 3Health News:Dylan Queen: Cheap Prom Dresses for the UK Market 2Health News:Various Styles of Bamboo Mats in Many Colors from BambooFlooringChina.com 2
(Date:12/19/2014)... 18, 2014   LaunchKey , the first decentralized ... and Internet of Things era, today announced the close ... round was led by Metamorphic Ventures with participation from ... VegasTechFund, and others.  LaunchKey has raised $4 million to ... its team and bring LaunchKey to market in 2015. ...
(Date:12/17/2014)... 2014 The Defense Logistics Agency is ... detect and prevent counterfeit microcircuits from entering into ... started performing an in-house microcircuit anti-counterfeit initiative dubbed ... of purchased microcircuits while increasing their reliability throughout ... will be conducted at DLA,s Electronics Product Test ...
(Date:12/17/2014)... 16, 2014 Valencell, a leader in performance ... technology to industry leaders such as Intel, Jabra, Atlas, ... biometric wearable products. These products will be showcased at ... Las Vegas . "Our partners ... and robust – with the clinical data to back ...
Breaking Biology News(10 mins):LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 3Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain 2Defense Logistics Agency Launches DNA Marking Capability to Strengthen Microcircuit Supply Chain 3Valencell PerformTek Biometrics Power the Most Accurate Wearables at CES 2015 2
Other Contents